Data Driven Methods for Kinase Drug Design

webinar

Thu, 27 Apr 2023, 16:00 CEST (Berlin)

Prof. Dr. Andrea Volkamer, Saarland University, Germany

Data Driven Methods for Kinase Drug Design

Human protein kinases are involved in several diseases which turned them into an important class for targeted therapy. To date there are almost 6,000 kinase structures in the PDB and around 70 small molecule kinase inhibitors available. Still several challenges remain related to drug promiscuity, resistance, and untapped kinase territory.

In this BioSolveIT webinar, Andrea will summarize the portfolio of methods which either use the openly available kinase data to generate new knowledge, or enable the community to engage in this data more easily. Using the TeachOpenCADD platform, she will demonstrate how to orchestrate diverse CADD tasks for individual kinases. Furthermore, Andrea’s lab developed freely available tools supporting diverse tasks: (i) KinFragLib for fragment based kinase inhibitor design, (ii) KiSSim – a KLIFS-based kinase structural similarity fingerprint, and (iii) a pipeline to assess kinase similarity from different data perspectives. All examples make use of the OpenCADD-KLIFS module to facilitate the integration of KLIFS data into kinase research workflows.

Andrea will close with further ongoing projects in structure-informed ML for kinase polypharmacology (openkinome).

Join us for an exciting talk and a vivid discussion.

Current news

category
Challenge
Winter 2026 Scientific Challenge Deadline Approaching
November 3, 2026 13:18 CET
The Winter 2026 Scientific Challenge is here! We invite researchers from academia (students, postdocs, and professors), non-profit organizations, and independent researchers to take part. Whether you are exploring a new drug discovery idea or looking to advance an existing project, our software can help you take your research further. How...
Read on
CORE by Onepot.AI – Access now with our tools
October 27, 2026 14:38 CET
Bringing Robotic Synthesis to Chemical Space Exploration A new Chemical Space is now available for your compound exploration: onepot’s CORE Space brings over 10 billion virtual product molecules to your drug discovery projects. CORE (Compounds On-demand via Robotic Execution) combines reactions widely used in medicinal chemistry with building blocks that...
Read on
A Milestone with Our Pioneering Partner: REAL Space Crosses 100 Billion
October 14, 2026 13:51 CEST
Crossing the 100 Billion Mark REAL Space has entered the 100+ billion era. The October update brings Enamine’s Chemical Space to 113,699,103,092 virtual product molecules, opening up an even larger collection of make-on-demand chemistry for your drug discovery projects. Built from 211,806 building blocks and 161 chemical reactions, implemented as...
Read on